First Trust Nasdaq Pharmaceuticals ETF
Nasdaq-listed fund. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving First Trust Nasdaq Pharmaceuticals ETF now
Current reporting with the operating signal separated from the noise.
Should You Invest in the First Trust NASDAQ Pharmaceuticals ETF (FTXH)?
The story matters when it changes First Trust Nasdaq Pharmaceuticals ETF’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest FTXH filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
No verified filing is shown until the official endpoint responds.
First Trust Nasdaq Pharmaceuticals ETF, quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →